Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Karo Bio initiates patient recruitment in eprotirome phase III trial for HeFH

The first patient has now been included in Karo Bio's phase III trial with eprotirome. A total of 630 patients with the hereditary condition HeFH will be studied for safety, and to confirm the beneficial effects on LDL-cholesterol that has been shown previously.

4 Oct 2011

Santaris Pharma to report new clinical data from miravirsen Phase 2a study on HCV

Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of microRNA and mRNA-targeted therapies, today announced the Company will report new clinical data results from the miravirsen Phase 2a proof-of-concept study to treat patients infected with the Hepatitis C virus (HCV) in a late-breaking oral presentation session at the American Association for the Study of Liver Diseases (AASLD) 2011 annual meeting.

4 Oct 2011

Men get type 2 diabetes at a lower BMI than women: Study

A latest study reveals that men need to gain little weight in order to develop type 2 diabetes as compared to women. A study carried out by clinical academics at Glasgow University found men developed the disease at a lower Body Mass Index than women, explaining why men have higher rates of diabetes in many parts of the world.

3 Oct 2011

MedCath sells Hualapai Mountain Medical Center and Louisiana Medical Center & Heart Hospital

MedCath Corporation announced that it has sold its interest in Louisiana Medical Center & Heart Hospital to Cardiovascular Care Group (CCG).

3 Oct 2011

Working in shifts associated with elevated levels of stress hormone cortisol

A recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM) found that shift work at a young age is associated with elevated long-term cortisol levels and increased BMI. Previous studies have shown that long-term elevated cortisol levels lead to increased abdominal obesity, hypertension, diabetes and cardiovascular risk.

3 Oct 2011

Scientists discover 16 million SNPs that associate with increased risk of ovarian cancer

Scientists at deCODE Genetics and academic collaborators from Iceland, The Netherlands, Spain and Finland today report the discovery of variants in the human genome that associate with increased risk of invasive ovarian cancer, one of the deadliest forms of cancer in women.

3 Oct 2011

Tight blood sugar control fails to improve memory in diabetics

A new study has shown that those with type 2 diabetes do not show slowing of the decline in thinking skills with intense blood sugar control. In fact such intense therapy raises risk of death.

2 Oct 2011

National Healing to merge with Diversified Clinical Services

National Healing Corporation, a provider of wound and disease management solutions for hospitals, and Diversified Clinical Services, also a provider of specialized wound care management services to hospitals, today announced that they have signed a definitive agreement under which the two companies will merge.

1 Oct 2011

Researchers examine link between innate exercise capacity and survivability

Aerobic exercise capacity has proven to be a good indicator of health. A recent paper in Circulation Research whose authors include researchers from the Norwegian University of Science and Technology's KG Jebsen Center of Exercise in Medicine uses a rat model to show that innate exercise capacity can be linked to longevity.

1 Oct 2011

Fat-rich 'western diet' fuels cardiovascular disease, type 2 diabetes and obesity

A major risk factor for cardiovascular disease, type 2 diabetes and other health- and life-threatening conditions, obesity is epidemic in the United States and other developed nations where it's fueled in large part by excessive consumption of a fat-rich "Western diet."

30 Sep 2011

HBI, TPF launch One Heart Magazine

Heartbeat International Foundation, Inc. (HBI), in partnership with The Publishing Firm Inc (TPF), today announced that it will launch its new publication, One Heart Magazine, to coincide with World Heart Day on September 29, 2011.

30 Sep 2011

VDC and P.A.D. Coalition present annual research awards at VDF's eighth annual meeting

The Venous Disease Coalition (VDC) and Peripheral Arterial Disease Coalition presented their annual research awards at the Vascular Disease Foundation's eighth annual meeting in Washington.

30 Sep 2011

Intensive blood glucose control therapy provides no added benefit against cognitive decline in older diabetics

Intensive control of blood sugar levels beyond standard targets provides no additional protection against cognitive decline in older people with diabetes than standard treatment, according to a national study coordinated by researchers at Wake Forest Baptist Medical Center.

29 Sep 2011

ACRO releases statement on World Heart Day

The Association of Clinical Research Organizations (ACRO), which represents the global leaders in clinical outsourcing, today released the following statement in recognition of World Heart Day.

29 Sep 2011

Genetic variant may increase severity of coronary artery disease in patients with diabetes

Researchers at Washington University School of Medicine in St. Louis have identified the first genetic variant associated with severity of coronary artery disease in patients with type 2 diabetes.

29 Sep 2011

People with prehypertension have higher risk of experiencing future stroke

People with prehypertension have a 55 percent higher risk of experiencing a future stroke than people without prehypertension, report researchers at the University of California, San Diego School of Medicine in a new meta-analysis of scientific literature published in the September 28 online issue of the journal Neurology.

29 Sep 2011

Valeant's colesevelam New Drug Submission for hypercholesterolemia receives Canadian approval

Valeant Pharmaceuticals International, Inc. announced that its wholly owned subsidiary, Valeant International (Barbados) SRL, has received notice that the New Drug Submission for colesevelam hydrochloride (colesevelam), an oral bile acid sequestrant for hypercholesterolemia, has been approved by the Canadian regulatory authority Health Canada.

28 Sep 2011

Takeda, AACE partner to launch Diabetes Navigator website

The American Association of Clinical Endocrinologists (AACE) and Takeda Pharmaceuticals North America Inc. (Takeda) have partnered to launch the Diabetes Navigator, a compendium capturing a selection of useful and reliable type 2 diabetes information available online for patients and caregivers.

28 Sep 2011

Dialog Devices receives CE mark and ISO certification for Padd

A ground-breaking device which "sees" beneath the skin to spot circulation problems has passed an important milestone on its journey to commercialisation.

28 Sep 2011

Engager Transcatheter Aortic Valve Implantation System pivotal trial to be conducted at 11 European centers

Medtronic, Inc. today announced the start of the Engager European Pivotal Trial to pursue CE Mark for the Engager Transcatheter Aortic Valve Implantation System in patients suffering from severe aortic stenosis.

From Medtronic 28 Sep 2011

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Karo Bio initiates patient recruitment in eprotirome phase III trial for HeFH

Santaris Pharma to report new clinical data from miravirsen Phase 2a study on HCV

Men get type 2 diabetes at a lower BMI than women: Study

MedCath sells Hualapai Mountain Medical Center and Louisiana Medical Center & Heart Hospital

Working in shifts associated with elevated levels of stress hormone cortisol

Scientists discover 16 million SNPs that associate with increased risk of ovarian cancer

Tight blood sugar control fails to improve memory in diabetics

National Healing to merge with Diversified Clinical Services

Researchers examine link between innate exercise capacity and survivability

Fat-rich 'western diet' fuels cardiovascular disease, type 2 diabetes and obesity

HBI, TPF launch One Heart Magazine

VDC and P.A.D. Coalition present annual research awards at VDF's eighth annual meeting

Intensive blood glucose control therapy provides no added benefit against cognitive decline in older diabetics

ACRO releases statement on World Heart Day

Genetic variant may increase severity of coronary artery disease in patients with diabetes

People with prehypertension have higher risk of experiencing future stroke

Valeant's colesevelam New Drug Submission for hypercholesterolemia receives Canadian approval

Takeda, AACE partner to launch Diabetes Navigator website

Dialog Devices receives CE mark and ISO certification for Padd

Engager Transcatheter Aortic Valve Implantation System pivotal trial to be conducted at 11 European centers

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in